Raised keratinocyte growth factor-1 expression in oral submucous fibrosis in vivo and upregulated by arecoline in human buccal mucosal fibroblasts in vitro

Journal of Oral Pathology and Medicine

Volumn 34, Issue 2, 2005, Pages 100-105

  Tsai, Chung Hung ^a   Yang, Shun Fa ^b   Chen, Yi Juai ^a   Chou, Ming Yung ^a   Chang, Yu Chao ^b  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Arecoline; Buccal mucosal fibroblasts; Keratinocyte growth factor 1; Oral submucous fibrosis

Indexed keywords

ALKALOID; ARECOLINE; KERATINOCYTE GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR 1; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; BETEL NUT; CELL CULTURE; CHEEK MUCOSA; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MALE; MESENCHYME CELL; MOUTH DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TAIWAN; UPREGULATION;

ARECOLINE; CELL CULTURE TECHNIQUES; FIBROBLAST GROWTH FACTOR 7; FIBROBLAST GROWTH FACTORS; FIBROBLASTS; HUMANS; MALE; MOUTH MUCOSA; ORAL SUBMUCOUS FIBROSIS; UP-REGULATION;

EID: 12444330872     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2004.00288.x     Document Type: Article

References (28)

1. Bourscer BJ, Mannan N. Metabolic effects of the consumption of areca catechu. Addict Biol 2002; 7: 103-10.
2. IARC. Betel-quid and Areca-nut Chewing. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Lyon: International Agency for Research on Cancer, 1985; 37: 141-202.
3. Trievdy CR, Craig G, Warnakulasuriya S. The oral health consequences of chewing areca nut. Addict Biol 2002; 7: 115-25.
4. Pindborg JJ. Oral submucous fibrosis: a review. Ann Acad Med Singapore 1989; 18: 603-7.
5. Chang YC, Yang SF, Tai KW, Chou MY, Hsieh YS. Increased tissue inhibitor of metalloproteinase-1 expression and inhibition of gelatinase A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis. Oral Oncol 2002; 38: 195-200.
6. Chang YC, Tsai CH, Tai KW, Yang SH, Chou MY, Lii CK. Elevated vimentin expression in buccal mucosal fibroblasts by arecoline in vitro as a possible pathogenesis for oral submucous fibrosis. Oral Oncol 2002; 38: 425-30.
7. Tsai CH, Chou MY, Chang YC. The upregulation of cyclooxygenase-2 expression in human buccal mucosal fibroblasts by arecoline: a possible role in the pathogenesis of oral submucous fibrosis. J Oral Pathol Med 2003; 32: 146-53.
8. Yang SF, Hsieh YS, Tsai CH, Chou MY, Chang YC. The upregulation of type I plasminogen activator inhibitor in oral submucous fibrosis. Oral Oncol 2003; 39: 367-72.
9. Hiragnn T, Morita E, Tanaka T, Kameyoshi Y, Yamamoto S. A fibrogenic cytokine, platelet-derived growth factor (PDGF), enhances mast cell growth indirectly via a SCF and fibroblast-dependent pathway. J Invest Dermatol 1998; 111: 213-7.
10. Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S. Aaronson SA. Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Nat Acad Sci USA 1989; 86: 802-6.
11. Werner S. Keratinocyte growth factor. Cytokine Growth Factor Rev 1998; 9: 153-63.
12. Partridge M, Kiguwa S, Luqman Y, Langdon JD. Expression of bFGF and FGF receptors on normal oral mucosa and SCC. Oral Oncol 1996; 23: 76-82.
13. DeBellis A, Crescioli C, Grappone C, et al. Expression and cellular localization of keratinocyte growth factor and its receptor in human hyperplastic prostate tissue. J Clin Endocrinol Metab 1998; 83: 2186-91.
14. Das SJ, Olsen I. The keratinocyte growth factor gene is up-regulated by the hyperplasia-inducing drug nifedipine. Cytokine 2000; 12: 1566-9.
15. Das SJ, Parkar MH, Olsen I. Upregulation of keratinocyte growth factor in cyclosporine A-induced gingival overgrowth. J Periodontol 2001; 72: 745-52.
16. Chang YC, Tai KW, Cheng MH, Chou LSS, Chou MY. Cytotoxic and non-genotoxic effects of arecoline on human buccal fibroblasts in vitro. J Oral Pathol Med 1998; 27: 68-71.
17. Chang YC, Tai KW, Chou MY, Tseng TH. Synergistic effects of peroxynitrite on arecoline-induced cytotoxicity in human buccal mucosal fibroblasts. Toxicol Lett 2000; 118: 61-8.
18. Chang YC, Hu CC, Tseng TH, Tai KW, Lii CK, Chou MY. Synergistic effects of nicotine on arecoline-induced cytotoxicity in human buccal mucosal fibroblasts. J Oral Pathol Med 2001; 30: 458-64.
19. McKeown STW, Hyland PL, Locke M, Mackenzie IC, Irwin CR. Keratinocyte growth factor expression by regionally defined oral fibroblasts. Eur J Oral Sci 2003; 111: 42-50.
20. Tsai CH, Hsieh YS, Yang SF, Chou MY, Chang YC. Matrix metalloproteinase 2 and 9 expression in human oral squamous cell carcinoma and the effect of protein kinase C inhibitors: preliminary observations. Oral Surg Oral Med Oral Pathol 2003; 95: 710-6.
21. Haque MF, Harris M, Meghji S, Barrett AW. Immunolocalization of cytokines and growth factors in oral submucous fibrosis. Cytokine 1998; 10: 713-9.
22. Haque MF, Meghji S, Khitab U, Harris M. Oral submucous fibrosis patients have altered levels of cytokine production. J Oral Pathol Med 2000; 29: 123-8.
23. Pilcher BK, Gaither-Ganim J, Parks WC, Welgus HG. Cell type-specific inhibition of keratinocyte collagenase-1 expression by basic fibroblast growth factor and keratinocyte growth factor. J Biol Chem 1997; 272: 18147-54.
24. Brauchle M, Angermeyer K, Hubner G, Werner S. Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts. Oncogene 1994; 9: 3199-204.
25. Ko SY, Lin SC, Chang KW, et al. Modulation of KGF-1 gene expression in oral fibroblasts by ripe areca nut extract. J Oral Pathol Med 2003; 32: 399-407.
26. Marchese C, Mancini P, Bellendi F, et al. Receptor-mediated endocytosis of keratinocyte growth factor. J Cell Sci 1998; 111: 3517-27.
27. Reichart PA, Phillipsen HP. Betel chewer's mucosa - a review. J Oral Pathol Med 1998; 27: 239-42.
28. Pillai R, Reddiar KS. Pathogenesis of oral submucous fibrosis. Relationship to risk factors associated with oral cancer. Cancer 1992; 69: 2011-20.